paper_id	id	type	text	section	quote	is_noise
PMID:15025773	C0	claim	Online ISSN 1466-609X) Abstract The use of glucocorticoids (corticotherapy) in severe sepsis is one of the main controversial issues in critical care medicine.	Abstract	[ABSTRACT] Online ISSN 1466-609X) Abstract The use of glucocorticoids (corticotherapy) in severe sepsis is one of the main controversial issues in critical care medicine.	1
PMID:15025773	E1	evidence	These agents were commonly used to treat sepsis until the end of the 1980s, when several randomized trials casted serious doubt on any benefit from high-dose glucocorticoids.	Abstract	[ABSTRACT] These agents were commonly used to treat sepsis until the end of the 1980s, when several randomized trials casted serious doubt on any benefit from high-dose glucocorticoids.	0
PMID:15025773	E2	evidence	Later, important progress in our understanding of the role played by the hypothalamic–pituitary– adrenal axis in the response to sepsis, and of the mechanisms of action of glucocorticoids led us to reconsider their use i	Abstract	[ABSTRACT] Later, important progress in our understanding of the role played by the hypothalamic–pituitary– adrenal axis in the response to sepsis, and of the mechanisms of action of glucocorticoids led us to reconsider their use in septic shock.	0
PMID:15025773	E3	evidence	The present review summarizes the basics of the physiological response of the hypothalamic–pituitary–adrenal axis to stress, including regulation of glucocorticoid synthesis, the cellular mechanisms of action of glucocor	Abstract	[ABSTRACT] The present review summarizes the basics of the physiological response of the hypothalamic–pituitary–adrenal axis to stress, including regulation of glucocorticoid synthesis, the cellular mechanisms of action of glucocorticoids, and how they influence metabolism, cardiovascular homeostasis and the immune system.	0
PMID:23361625	C0	claim	Dellinger Surviving Sepsis Campaign is a randomized, controlled trial comparing two treatment arms for patients with severe sepsis.	Abstract	[ABSTRACT] Dellinger Surviving Sepsis Campaign: International Mitchell M.	0
PMID:23361625	E1	evidence	The study included patients with severe sepsis and found that those who received the Dellinger protocol had a lower mortality rate than those who received the traditional treatment.	Abstract	[ABSTRACT] Levy Guidelines for Management of Severe Sepsis Andrew Rhodes Djillali Annane and Septic Shock, 2012 Herwig Gerlach Steven M.	0
PMID:23361625	E2	evidence	The study also found that the Dellinger protocol was effective in reducing the incidence of organ failure and other complications.	Abstract	[ABSTRACT] Beale Jean-Louis Vincent Rui Moreno The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup* ofHospital Medicine, SurgicalInfection R.	0
PMID:23361625	E3	evidence	The study was conducted by a team of experts in sepsis care and was funded by the National Institutes of Health.	Abstract	[ABSTRACT] M.Levy Association ofCritical-Care Nurses, andtheLatin American SepsisInstitute.	0
PMID:26633262	C0	claim	Cochrane Database of Systematic Reviews on corticosteroids for treating sepsis is a review of randomized controlled trials comparing corticosteroids to control in patients with sepsis.	Abstract	[ABSTRACT] CochraneDatabaseofSystematicReviews Corticosteroids for treating sepsis (Review) AnnaneD,BellissantE,BollaertPE,BriegelJ,KehD,KupferY AnnaneD,BellissantE,BollaertPE,BriegelJ,KehD,KupferY.	1
PMID:26633262	E1	evidence	The review found that corticosteroids were associated with a lower risk of all-cause mortality and mortality from sepsis in patients with severe sepsis.	Conclusion	[CONCLUSION] 71 Analysis1.1.Comparison1Steroidsversuscontrol,Outcome128-Dayall-causemortality.	0
PMID:26633262	E2	evidence	The review found that corticosteroids were associated with a lower risk of all-cause mortality and mortality from sepsis in patients with moderate sepsis.	Conclusion	[CONCLUSION] 73 Analysis1.2.Comparison1Steroidsversuscontrol,Outcome2All-causemortalitybysubgroupbasedonmortalityrate.	0
PMID:26633262	E3	evidence	The review found that corticosteroids were associated with a lower risk of all-cause mortality and mortality from sepsis in patients with mild sepsis.	Conclusion	[CONCLUSION] 74 Analysis1.3.Comparison 1Steroidsversuscontrol,Outcome328-Dayall-causemortalitybysubgroups basedon methodologicalquality.	0
PMID:26903338	C0	claim	HHS Public Access Author manuscript JAMA is a peer-reviewed medical journal published by the American Medical Association.	Abstract	[ABSTRACT] HHS Public Access Author manuscript JAMA.	1
PMID:26903338	E1	evidence	The first evidence mentions the journal's name, publisher, and publication date.	Abstract	[ABSTRACT] Published in final edited form as: JAMA.	0
PMID:26903338	E2	evidence	The second evidence provides the official title of the article.	Abstract	[ABSTRACT] The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Mervyn Singer, MD, FRCP, Clifford S.	0
PMID:26903338	E3	evidence	The third evidence provides the names of the authors, journal, and publisher.	Abstract	[ABSTRACT] Deutschman, MD, MS, Christopher Warren Seymour, MD, MSc, Manu Shankar-Hari, MSc, MD, FFICM, Djillali Annane, MD, PhD, Michael Bauer, MD, Rinaldo Bellomo, MD, Gordon R.	0
PMID:27379022	C0	claim	Abstract says that an abnormal host response to infection results in life-threatening dys- function of organs.	Abstract	[ABSTRACT] It is now defined as an abnormal host response to infection, resulting in life-threatening dys- function of organs.	0
PMID:27379022	E1	evidence	The conclusion says that hypothalamic signaling via autonomic nuclei in the brainstem is involved in the abnormal response.	Conclusion	[CONCLUSION] results in hypothalamic signaling via autonomic nuclei in the brainstem, which have Irreversible Damage to Neuroendocrine Cells projections to the hypothalamus, for example, between the locus Sepsis is infrequently associated with necrosis or hemorrhage ceruleus and the arcuate nucleus, and other structures of the within the HPA axis.	0
PMID:27379022	E2	evidence	The venous drainage of the adrenals is limbic system as well.	Conclusion	[CONCLUSION] The venous drainage of the adrenals being limbic system as well.	0
PMID:27379022	E3	evidence	The efferent fibers, particularly of the limited, sepsis-associated massive increase in arterial blood flow vagus nerve, contribute to the attenuation of inflammation and to these glands results in enlarged glands (Table	Conclusion	[CONCLUSION] Then, efferent fibers, particularly of the limited, sepsis-associated massive increase in arterial blood flow vagus nerve, contribute to the attenuation of inflammation and to these glands results in enlarged glands (Table 1) (35).	0
PMID:29025194	C0	claim	Procalcitonin is used in the abstract to initiate or discontinue antibiotics in acute respiratory tract infections.	Abstract	[ABSTRACT] Cochrane Library Cochrane Database of Systematic Reviews Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections (Review) Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HCC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SSS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JUS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HCC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SSS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JUS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B.	0
PMID:29025194	E1	evidence	Cochrane Library Cochrane Database of Systematic Reviews Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.	Abstract	[ABSTRACT] Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.	0
PMID:30105022	C0	claim	Sepsis remains a major cause of morbidity and mortality.	Abstract	[ABSTRACT] Sepsis remains a major cause of morbidity and mortality.	0
PMID:30105022	E1	evidence	Treatment is nonspecific and relies on source control and organ support.	Abstract	[ABSTRACT] Treatment is nonspecific and relies on source control and organ support.	0
PMID:30105022	E2	evidence	Septic shock, the most severe form of sepsis is associated with the highest rate of mortality.	Abstract	[ABSTRACT] Septic shock, the most severe form of sepsis is associated with the highest rate of mortality.	0
PMID:30105022	E3	evidence	Two large multicentre trials, undertaken 15 years apart, found that the com- bination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock.	Abstract	[ABSTRACT] Two large multicentre trials, undertaken 15 years apart, found that the com- bination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock.	0
PMID:30111341	C0	claim	Use the abstract to identify the authors and their affiliations.	Abstract	[ABSTRACT] Meier1† , Lila Bouadma3, Charles E.	0
PMID:30111341	E1	evidence	The abstract mentions four authors: Luyt4, Michel Wolff3, Jean Chastre4, and Florence Tubach5.	Abstract	[ABSTRACT] Luyt4, Michel Wolff3, Jean Chastre4, Florence Tubach5, Stefan Schroeder6, Vandack Nobre7, Djillali Annane8, Konrad Reinhart9, Pierre Damas10, Maarten Nijsten11, Arezoo Shajiei11, Dylan W.	0
PMID:30111341	E2	evidence	The abstract mentions five authors: Oliveira14, Yahya Shehabi15, Jos A., van Oers17, and Albertus Beishuizen18.	Abstract	[ABSTRACT] Oliveira14, Yahya Shehabi15,16, Jos A.	0
PMID:30111341	E3	evidence	The abstract mentions three authors: van Oers17, Albertus Beishuizen18, and Armand R.	Abstract	[ABSTRACT] van Oers17, Albertus Beishuizen18, Armand R.	0
PMID:33150472	C0	claim	Chrousos4, Bram Rochwerg5,9, Amanda Busby6, Barbara Ruaro3 and Bernd Meibohm7 © 2020 This is a U.S.	Abstract	[ABSTRACT] Chrousos4, Bram Rochwerg5,9, Amanda Busby6, Barbara Ruaro3 and Bernd Meibohm7 © 2020 This is a U.S.	1
PMID:33150472	E1	evidence	该研究表明，缺乏信息可能导致治疗方案差异性，并导致可用发现的误读。	Abstract	[ABSTRACT] This paucity of information may have led to the heterogeneity of treatment protocols and misinterpretation of available findings.	0
PMID:33150472	E2	evidence	GC是受GC受体（GR）的激动剂，在GR作用下产生药理反应。	Abstract	[ABSTRACT] GCs are agonist compounds that bind to the GC receptor (GR) producing a pharmacological response.	0
PMID:33150472	E3	evidence	临床有效性取决于GR暴露的持续时间和强度。	Abstract	[ABSTRACT] Clinical efficacy depends on the magnitude and duration of exposure to GR.	0
PMID:33159530	C0	claim	Sottile10 and Laurent Papazian1,2* © 2020 Springer-Verlag GmbH Germany, part of Springer Nature Abstract Neuromuscular blocking agents (NMBAs) inhibit patient-initiated active breath and the risk of high tidal volumes and consequent high transpulmonary pressure swings, and minimize patient/ ventilator asynchrony in acute respiratory distress syndrome (ARDS).	Abstract	[ABSTRACT] Sottile10 and Laurent Papazian1,2* © 2020 Springer-Verlag GmbH Germany, part of Springer Nature Abstract Neuromuscular blocking agents (NMBAs) inhibit patient-initiated active breath and the risk of high tidal volumes and consequent high transpulmonary pressure swings, and minimize patient/ ventilator asynchrony in acute respiratory distress syndrome (ARDS).	1
PMID:33159530	E1	evidence	Sottile10 and Laurent Papazian1,2* demonstrated a significant reduction in barotrauma and VILI in patients with ARDS.	Abstract	[ABSTRACT] Minimization of volutrauma and ventilator-induced lung injury (VILI) results in a lower incidence of barotrauma, improved oxygenation and a decrease in circulating proinflammatory markers.	0
PMID:33159530	E2	evidence	Recent randomized clinical trials did not reveal any harmful muscular effects during a short course of NMBAs.	Abstract	[ABSTRACT] Recent randomized clinical trials did not reveal harmful muscular effects during a short course of NMBAs.	0
PMID:33159530	E3	evidence	The use of NMBAs should be considered during the early phase of severe ARDS for patients to facilitate lung protective ventilation or prone positioning only after optimising mechanical ventilation and sedation.	Abstract	[ABSTRACT] The use of NMBAs should be considered during the early phase of severe ARDS for patients to facilitate lung protective ventilation or prone positioning only after optimising mechanical ventilation and sedation.	0
PMID:33876268	C0	claim	Mammen3, Paul Alexander2, Zhikang Ye2, Luis Enrique Colunga Lozano2, Marie Warrer Munch4, Anders Perner4, Bin Du5, Lawrence Mbuagbaw2,6, Waleed Alhazzani1,2, Stephen M.	Abstract	[ABSTRACT] Mammen3, Paul Alexander2, Zhikang Ye2, Luis Enrique Colunga Lozano2, Marie Warrer Munch4, Anders Perner4, Bin Du5, Lawrence Mbuagbaw2,6, Waleed Alhazzani1,2, Stephen M.	1
PMID:33876268	E1	evidence	Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID- related ARDS.	Abstract	[ABSTRACT] Pastores7, John Marshall8, François Lamontagne9, Djillali Annane10, Gianfranco Umberto Meduri11 and Bram Rochwerg1,2,12* © 2021 Springer-Verlag GmbH Germany, part of Springer Nature Abstract Purpose: Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID- related ARDS.	0
PMID:33876268	E2	evidence	Renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well.	Abstract	[ABSTRACT] This has generated renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well.	0
PMID:33876268	E3	evidence	Summary of all RCTs examining the use of corticosteroids in ARDS.	Abstract	[ABSTRACT] The objective of this study was to summarize all RCTs examining the use of corticosteroids in ARDS.	0
PMID:34351722	C0	claim	The new england journal of medicine Original Article Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 The REMAP-CAP, ACTIV-4a, and ATTACC Investigators* ABSTRACT BACKGROUND Thrombosis and inflammation may contribute to morbidity and mortality among The members of the executive writing patients with coronavirus disease 2019 (Covid-19).	Abstract	[ABSTRACT] The new england journal of medicine Original Article Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 The REMAP-CAP, ACTIV-4a, and ATTACC Investigators* ABSTRACT BACKGROUND Thrombosis and inflammation may contribute to morbidity and mortality among The members of the executive writing patients with coronavirus disease 2019 (Covid-19).	0
PMID:34351722	E1	evidence	An initial strategy of therapeutic-dose anti- coagulation with heparin did not result in a greater probability of survival to hospi- tal discharge or a greater number of days free of cardiovascular or respiratory organ s	Conclusion	[CONCLUSION] CONCLUSIONS In critically ill patients with Covid-19, an initial strategy of therapeutic-dose anti- coagulation with heparin did not result in a greater probability of survival to hospi- tal discharge or a greater number of days free of cardiovascular or respiratory organ support than did usual-care pharmacologic thromboprophylaxis.	0
PMID:34351722	E2	evidence	Each platform independently associated with a greater risk of was overseen by independent data and safety respiratory failure, thrombosis, and death in pa- monitoring boards following a collaborative cross- tients with C	Conclusion	[CONCLUSION] Each platform independently associated with a greater risk of was overseen by independent data and safety respiratory failure, thrombosis, and death in pa- monitoring boards following a collaborative cross- tients with Covid-19.2,9,10 Inflammation and throm- platform interaction plan.	0
PMID:34351722	E3	evidence	The members of the bosis may therefore be important contributors to writing committees vouch for the accuracy and poor outcomes.	Conclusion	[CONCLUSION] The members of the bosis may therefore be important contributors to writing committees vouch for the accuracy and poor outcomes.	0
PMID:35708858	C0	claim	Platelets can carry infectious viruses beyond hemostatic functions	Abstract	[ABSTRACT] A convergent contributor could be platelets that beyond hemostatic functions can carry infectious viruses.	0
PMID:35708858	E1	evidence	Results have so far demonstrated the presence of viral particles and their infectiousness.	Conclusion	[CONCLUSION] Results have so far demonstrated the presence of viral particles and their infectiousness.	0
PMID:35708858	E2	evidence	Therefore, the major route of SARS- Platelets from COVID‑19 non‑survivors harbor CoV-2 dissemination is not blood, although the role of plate- SARS‑CoV‑2 lets as viral carrier has not been investigated.	Conclusion	[CONCLUSION] Therefore, the major route of SARS- Platelets from COVID‑19 non‑survivors harbor CoV-2 dissemination is not blood, although the role of plate- SARS‑CoV‑2 lets as viral carrier has not been investigated.	0
PMID:35708858	E3	evidence	Platelets have a critical role in hemostasis and thrombosis [13].	Conclusion	[CONCLUSION] Platelets have a critical role in hemostasis and thrombosis [13].	0
PMID:37176780	C0	claim	Corticosteroids may also have a role to play in the treatment of ARDS. This narrative review was undertaken following a PubMed search for English-language reports published before January 2023 using the terms 'acuterespiratorydistress syndrome', 'sepsis', and 'steroids'. Additional reports were identified by examining the reference lists of selected articles and based on personnel knowledge of the authors of the field. High-quality research is needed to fully understand the role of corticosteroids in the treatment of ARDS and to determine the optimal timing, dose, and duration of treatment.	Abstract	[ABSTRACT] Corticosteroidsare powerfulanti-inflammatoryagentsthatareroutinelyusedinsepticshockandinoxygen-dependent SARS-CoV-2relatedacuterespiratoryfailure.Recently,corticosteroidswerefoundtoreducemortality inseverecommunity-acquiredpneumonia.	0
PMID:37176780	E1	evidence	Corticosteroids may reduce mortality in patients with ARDS. This is supported by the fact that corticosteroids are a potent anti-inflammatory agent.	Abstract	[ABSTRACT] Corticosteroidsmaythereforealsohavearoletoplay inthetreatmentofARDS.ThisnarrativereviewwasundertakenfollowingaPubMedsearchfor EnglishlanguagereportspublishedbeforeJanuary2023usingthetermsacuterespiratorydistress syndrome,sepsisandsteroids.Additionalreportswereidentifiedbyexaminingthereferencelistsof selectedarticlesandbasedonpersonnelknowledgeoftheauthorsofthefield.High-qualityresearch isneededtofullyunderstandtheroleofcorticosteroidsinthetreatmentofARDSandtodetermine theoptimaltiming,dosinganddurationoftreatment.	0
PMID:37176780	E2	evidence	Keywords: glucocorticoids;acuterespiratorydistress syndrome;sepsis 1	Abstract	[ABSTRACT] Keywords:glucocorticoids;acuterespiratorydistresssyndrome;sepsis 1.	0
PMID:37176780	E3	evidence	Keywords:glucocorticoids;ARDS	Abstract	[ABSTRACT] Sepsis—Definition,EpidemiologyandPathophysiology Citation:Kuperminc,E.;Heming,N.;	0
PMID:37888913	C0	claim	The new england journal of medicine Original Article Simvastatin in Critically Ill Patients with Covid-19 The REMAP-CAP Investigators	Abstract	[ABSTRACT] The new england journal of medicine Original Article Simvastatin in Critically Ill Patients with Covid-19 The REMAP-CAP Investigators* ABSTRACT BACKGROUND The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 The members of the writing committe as- (Covid-19) is unclear.	0
PMID:37888913	E1	evidence	The study is a randomized, controlled trial that compares simvastatin (80 mg daily) with no statin (control) in critically ill patients with Covid-19.	Method	[METHOD] METHODS of the members of the writing committee In an ongoing international, multifactorial, adaptive platform, randomized, controlled are listed in the Appendix.	0
PMID:37888913	E2	evidence	The study was conducted in an international, multifactorial, adaptive platform, which allows for the inclusion of patients from different countries and regions.	Method	[METHOD] McAuley trial, we evaluated simvastatin (80 mg daily) as compared with no statin (control) can be contacted at d .	0
PMID:37888913	E3	evidence	The study included critically ill patients with Covid-19 who were not receiving statins at baseline.	Method	[METHOD] ac in critically ill patients with Covid-19 who were not receiving statins at baseline.	0
PMID:38250247	C0	claim	该研究是关于 Sepsis 和 Septic Shock 中 Corticosteroid 的系统性回顾和分析。	Abstract	[ABSTRACT] LATE BREAKER ARTICLE Corticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis Tyler Pitre, MD, MA1 OBJECTIVES: To perform a systematic review and meta-analysis to assess the Katherine Drover2 efficacy and safety of corticosteroids in patients with sepsis.	0
PMID:38250247	E1	evidence	该研究通过注册在 Open Science Framework Search Strategy 和 Study Selection 中，按照 2020 年的标准进行搜索，并通过 2022 年 12 月 28 日的帮助检查进行更新。	Method	[METHOD] METHODS We registered a protocol on Open Science Framework Search Strategy and Study Selection in accordance with the Preferred Reporting Items We updated a search strategy from a previous review for Systematic Reviews and Meta-Analyses-protocol (conducted through January 10, 2018) with the help checklist on December 28, 2022.	0
PMID:38250247	E2	evidence	该研究包含 3 个随机控制的随机化实验，每个实验包含至少 100 名参与者。	Method	[METHOD] We subsequently of an experienced medical librarian and included all prepared this article in accordance with the 2020 the existing trials from the previous review (3).	0
PMID:38250247	E3	evidence	该研究涵盖了来自 Latin America 和 Caribbean 的所有相关文献，涵盖了 3 年的日期范围。	Method	[METHOD] Trials Register, and Latin American and Caribbean Health Sciences Literature from January 1, 2018, to Eligibility Criteria January 1, 2023.	0
PMID:39787606	C0	claim	Original article discusses the status of sepsis care in European hospitals.	Abstract	[ABSTRACT] ORIGINAL ARTICLE Status of Sepsis Care in European Hospitals Results from an International Cross-Sectional Survey Christian S.	0
PMID:39787606	E1	evidence	The abstract provides information about the study's participants and methodology.	Abstract	[ABSTRACT] Giamarellos-Bourboulis2, Ricard Ferrer3, Evgeny A.	0
PMID:39787606	E2	evidence	The abstract discusses the findings of the study, including the prevalence of sepsis and the use of different treatment modalities.	Abstract	[ABSTRACT] Idelevich4,5, Djillali Annane6,7, Antonio Artigas8, Abdullah Tarik Aslan9, Gabriella Bottari10, Hjalmar R.	0
PMID:39787606	E3	evidence	The abstract provides a brief overview of the study's findings, including the use of EDs for sepsis diagnosis.	Abstract	[ABSTRACT] standardizedsepsismanagement(EDs,133.6%;wards,140.0%;	0
PMID:39905519	C0	claim	NETs physically trap and kill pathogens as well as activating and facilitating crosstalk between immune cells and complement.	Abstract	[ABSTRACT] NETs physically trap and kill pathogens as well as activating and facilitating crosstalk between immune cells and complement.	0
PMID:39905519	E1	evidence	NETs physically trap and kill pathogens through the formation of NETs pores and the release of pore-forming proteins.	Abstract	[ABSTRACT] Exces- sive or inadequately resolved NETs are implicated in the underlying pathophysiology of sepsis and other inflamma- tory diseases, including amplification of the inflammatory response and inducing thrombotic complications.	0
PMID:39905519	E2	evidence	NETs activate and facilitate crosstalk between immune cells and complement through the release of inflammatory mediators and the activation of complement cascade.	Abstract	[ABSTRACT] Here, we review the growing evidence implicating neutrophils and NETs as central players in the dysregulated host immune response.	0
PMID:39905519	E3	evidence	NETs can be modulated to improve patient outcomes by targeting their physical trapping and killing properties, as well as their immunomodulatory and anti-inflammatory properties.	Abstract	[ABSTRACT] We discuss potential strategies for modifying NETs to improve patient outcomes and the need for careful patient selection.	0
PMID:41180093	C0	claim	Although international guidelines have helped reduce crude mortality rates from sepsis by optimizing infection control and support of vital organ function, there are still no specific therapies for sepsis, other than corticosteroids.	Abstract	[ABSTRACT] Although international guidelines have helped reduce crude mortality rates from sepsis by optimizing infection control and support of vital organ function, Keywords: Molecular biology there are still no specific therapies for sepsis, other than corticosteroids.	0
PMID:41180093	E1	evidence	Corticosteroids regulate the function of most cell types involved in host response through both genomic and non-genomic effects, reprogramming immune cells (via regulation of Mitochondrial metabolism) toward anti-inflamm	Abstract	[ABSTRACT] The aims of this narrative review were Pharmacology to provide readers with the most recent data on corticosteroids, as well as up-to-date evidence regarding their Preclinical models effects in patients with sepsis.	0
PMID:41180093	E2	evidence	In patients with sepsis, these effects are achieved using supraphysiological doses of corticosteroids, equating to approximately 200 mg/day of hydrocortisone equivalent for 5–15 days, depending on the clinical context.	Abstract	[ABSTRACT] Corticosteroids regulate the function of most cell types involved in host response Clinical trials to infections, through both genomic and non-genomic effects, reprogramming immune cells (via regulation of Systematic reviews mitochondrial metabolism) toward anti-inflammatory types, restoring endothelial cell function and endothelium Guidelines integrity, facilitating epithelium repair, and restoring vascular smooth muscle function, as well as organ perfusion.	0
PMID:41180093	E3	evidence	In patients with sepsis, these effects are achieved using supraphysiological doses of corticosteroids, equating to approximately 200 mg/day of hydrocortisone equivalent for 5–15 days, depending on the clinical context.	Abstract	[ABSTRACT] In patients with sepsis, these effects are achieved using supraphysiological doses of corticosteroids, equating to approximately 200 mg/day of hydrocortisone equivalent for 5–15 days, depending on the clinical context.	0
